PubMed:25315623
Annnotations
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 44-59 | REPLACED | denotes | High-conductive |
| T2 | 78-257 | DRI_Background | denotes | potassium channels (BK+Ca) and ATP-sensitive potassium (K+ATP) channels play a significant role in the airway smooth muscle cell and goblet cell function, and cytokine production. |
| T3 | 258-427 | DRI_Background | denotes | The present study evaluated the therapeutic potential of BK+Ca and K+ATP openers, NS 1619 and pinacidil, respectively, in an experimental model of allergic inflammation. |
| T4 | 428-586 | DRI_Background | denotes | Airway allergic inflammation was induced with ovalbumine in guinea pigs during 21 days, which was followed by a 14-day treatment with BK+Ca and K+ATP openers. |
| T5 | 587-823 | DRI_Background | denotes | The outcome measures were airway smooth muscle cells reactivity in vivo and in vitro, cilia beating frequency and the level of exhaled NO (ENO), and the level of pro-inflammatory cytokines in the plasma and bronchoalveolar lavage fluid. |
| T6 | 824-960 | DRI_Outcome | denotes | The openers of both channels decreased airway smooth muscle cells reactivity, cilia beating frequency, and cytokine levels in the serum. |
| T7 | 961-1029 | DRI_Background | denotes | Furthermore, NS1619 reduced ENO and inflammatory cells infiltration. |
| T8 | 1030-1144 | DRI_Challenge | denotes | The findings confirmed the presence of beneficial effects of BK+Ca and K+ATP openers on airway defence mechanisms. |
| T9 | 1145-1296 | DRI_Outcome | denotes | Although both openers dampened pro-inflammatory cytokines and mast cells infiltration, an evident anti-inflammatory effect was provided only by NS1619. |
| T10 | 1297-1438 | DRI_Challenge | denotes | Therefore, we conclude that particularly BK+Ca channels represent a promising new drug target in treatment of airway's allergic inflammation. |
Goldhamster2_Cellosaurus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 101-103 | CVCL_Z839|Spontaneously_immortalized_cell_line|Drosophila melanogaster | denotes | Ca |
| T2 | 155-156 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
| T3 | 318-320 | CVCL_Z839|Spontaneously_immortalized_cell_line|Drosophila melanogaster | denotes | Ca |
| T4 | 380-382 | CVCL_8754|Cancer_cell_line|Homo sapiens | denotes | an |
| T5 | 380-382 | CVCL_H241|Cancer_cell_line|Homo sapiens | denotes | an |
| T6 | 538-542 | CVCL_6309|Cancer_cell_line|Homo sapiens | denotes | a 14 |
| T7 | 538-542 | CVCL_L990|Spontaneously_immortalized_cell_line|Mus musculus | denotes | a 14 |
| T8 | 538-539 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
| T9 | 540-542 | CVCL_ZS48|Finite_cell_line|Homo sapiens | denotes | 14 |
| T10 | 565-567 | CVCL_Z839|Spontaneously_immortalized_cell_line|Drosophila melanogaster | denotes | Ca |
| T11 | 749-752 | CVCL_N817|Cancer_cell_line|Homo sapiens | denotes | pro |
| T12 | 1094-1096 | CVCL_Z839|Spontaneously_immortalized_cell_line|Drosophila melanogaster | denotes | Ca |
| T13 | 1176-1179 | CVCL_N817|Cancer_cell_line|Homo sapiens | denotes | pro |
| T14 | 1207-1211 | CVCL_M374|Cancer_cell_line|Homo sapiens | denotes | mast |
| T15 | 1232-1234 | CVCL_8754|Cancer_cell_line|Homo sapiens | denotes | an |
| T16 | 1232-1234 | CVCL_H241|Cancer_cell_line|Homo sapiens | denotes | an |
| T17 | 1308-1310 | CVCL_5M23|Cancer_cell_line|Mesocricetus auratus | denotes | we |
| T18 | 1341-1343 | CVCL_Z839|Spontaneously_immortalized_cell_line|Drosophila melanogaster | denotes | Ca |
| T19 | 1363-1364 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
GoldHamster
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 0-13 | 1318915 | denotes | Potassium ion |
| T7 | 0-22 | D015221 | denotes | Potassium ion channels |
| T10 | 10-22 | GO:0022831 | denotes | ion channels |
| T11 | 36-42 | D001249 | denotes | asthma |
| T12 | 36-42 | D001249 | denotes | asthma |
| T13 | 60-67 | 1895 | denotes | calcium |
| T14 | 60-67 | CHEBI:29320 | denotes | calcium |
| T15 | 60-67 | CHEBI:22984 | denotes | calcium |
| T19 | 78-87 | 8588 | denotes | potassium |
| T20 | 78-96 | D015221 | denotes | potassium channels |
| T22 | 109-112 | 318 | denotes | ATP |
| T21 | 109-112 | D000255 | denotes | ATP |
| T23 | 109-112 | CHEBI:30616 | denotes | ATP |
| T24 | 109-112 | D000255 | denotes | ATP |
| T25 | 109-112 | CHEBI:15422 | denotes | ATP |
| T29 | 123-132 | 8588 | denotes | potassium |
| T26 | 123-132 | D011188 | denotes | potassium |
| T27 | 123-132 | D011188 | denotes | potassium |
| T28 | 123-132 | CHEBI:26216 | denotes | potassium |
| T31 | 136-139 | 318 | denotes | ATP |
| T30 | 136-139 | D000255 | denotes | ATP |
| T32 | 136-139 | CHEBI:30616 | denotes | ATP |
| T33 | 136-139 | D000255 | denotes | ATP |
| T34 | 136-139 | CHEBI:15422 | denotes | ATP |
| T38 | 181-206 | UBERON:0004225 | denotes | airway smooth muscle cell |
| T41 | 188-206 | CL:0000192 | denotes | smooth muscle cell |
| T45 | 211-222 | CL:0000160 | denotes | goblet cell |
| T46 | 237-256 | GO:0001816 | denotes | cytokine production |
| T48 | 327-330 | 318 | denotes | ATP |
| T47 | 327-330 | D000255 | denotes | ATP |
| T49 | 327-330 | CHEBI:30616 | denotes | ATP |
| T50 | 327-330 | D000255 | denotes | ATP |
| T51 | 327-330 | CHEBI:15422 | denotes | ATP |
| T52 | 340-347 | CHEBI:34879 | denotes | NS 1619 |
| T53 | 340-347 | C086491 | denotes | NS 1619 |
| T54 | 340-347 | C086491 | denotes | NS 1619 |
| T55 | 352-361 | D020110 | denotes | pinacidil |
| T56 | 352-361 | CHEBI:34923 | denotes | pinacidil |
| T57 | 352-361 | CHEBI:91706 | denotes | pinacidil |
| T58 | 352-361 | D020110 | denotes | pinacidil |
| T59 | 414-426 | GO:0006954 | denotes | inflammation |
| T60 | 414-426 | D007249 | denotes | inflammation |
| T61 | 414-426 | D007249 | denotes | inflammation |
| T62 | 428-434 | UBERON:0000117 | denotes | Airway |
| T63 | 428-434 | UBERON:0001005 | denotes | Airway |
| T64 | 444-456 | GO:0006954 | denotes | inflammation |
| T65 | 444-456 | D007249 | denotes | inflammation |
| T66 | 444-456 | D007249 | denotes | inflammation |
| T67 | 488-499 | D006168 | denotes | guinea pigs |
| T68 | 495-499 | PR:Q9W3Y4 | denotes | pigs |
| T71 | 495-499 | PR:Q6PD26 | denotes | pigs |
| T72 | 495-499 | PR:Q5XI31 | denotes | pigs |
| T73 | 495-499 | PR:Q96S52 | denotes | pigs |
| T74 | 495-499 | PR:000012706 | denotes | pigs |
| T79 | 574-577 | 318 | denotes | ATP |
| T78 | 574-577 | D000255 | denotes | ATP |
| T80 | 574-577 | CHEBI:30616 | denotes | ATP |
| T81 | 574-577 | D000255 | denotes | ATP |
| T82 | 574-577 | CHEBI:15422 | denotes | ATP |
| T85 | 613-633 | UBERON:0004225 | denotes | airway smooth muscle |
| T90 | 673-678 | UBERON:0001702 | denotes | cilia |
| T91 | 673-678 | UBERON:0010168 | denotes | cilia |
| T92 | 726-729 | PR:P0A6P9 | denotes | ENO |
| T93 | 726-729 | PR:P15007 | denotes | ENO |
| T94 | 726-729 | PR:Q2G028 | denotes | ENO |
| T95 | 726-729 | PR:000022518 | denotes | ENO |
| T96 | 749-752 | CVCL_N817 | denotes | pro |
| T100 | 749-752 | SO:0001439 | denotes | pro |
| T97 | 749-752 | CHEBI:32871 | denotes | pro |
| T98 | 749-752 | CHEBI:32865 | denotes | pro |
| T99 | 749-752 | CHEBI:50342 | denotes | pro |
| T101 | 749-752 | CHEBI:32866 | denotes | pro |
| T102 | 766-775 | D016207 | denotes | cytokines |
| T103 | 766-775 | D016207 | denotes | cytokines |
| T104 | 783-789 | UBERON:0001969 | denotes | plasma |
| T105 | 817-822 | UBERON:0006314 | denotes | fluid |
| T108 | 863-883 | UBERON:0004225 | denotes | airway smooth muscle |
| T113 | 902-907 | UBERON:0001702 | denotes | cilia |
| T114 | 902-907 | UBERON:0010168 | denotes | cilia |
| T115 | 954-959 | UBERON:0001977 | denotes | serum |
| T116 | 974-980 | CHEBI:34879 | denotes | NS1619 |
| T117 | 974-980 | C086491 | denotes | NS1619 |
| T118 | 974-980 | C086491 | denotes | NS1619 |
| T119 | 989-992 | PR:P0A6P9 | denotes | ENO |
| T120 | 989-992 | PR:P15007 | denotes | ENO |
| T121 | 989-992 | PR:Q2G028 | denotes | ENO |
| T122 | 989-992 | PR:000022518 | denotes | ENO |
| T124 | 1103-1106 | 318 | denotes | ATP |
| T123 | 1103-1106 | D000255 | denotes | ATP |
| T125 | 1103-1106 | CHEBI:30616 | denotes | ATP |
| T126 | 1103-1106 | D000255 | denotes | ATP |
| T127 | 1103-1106 | CHEBI:15422 | denotes | ATP |
| T128 | 1118-1124 | UBERON:0000117 | denotes | airway |
| T129 | 1118-1124 | UBERON:0001005 | denotes | airway |
| T130 | 1176-1179 | CVCL_N817 | denotes | pro |
| T134 | 1176-1179 | SO:0001439 | denotes | pro |
| T131 | 1176-1179 | CHEBI:32871 | denotes | pro |
| T132 | 1176-1179 | CHEBI:32865 | denotes | pro |
| T133 | 1176-1179 | CHEBI:50342 | denotes | pro |
| T135 | 1176-1179 | CHEBI:32866 | denotes | pro |
| T136 | 1193-1202 | D016207 | denotes | cytokines |
| T137 | 1193-1202 | D016207 | denotes | cytokines |
| T138 | 1207-1211 | PR:Q9NBD7 | denotes | mast |
| T139 | 1207-1211 | PR:000008154 | denotes | mast |
| T141 | 1207-1211 | Q9NBD7 | denotes | mast |
| T142 | 1207-1211 | Q7TPM5 | denotes | mast |
| T140 | 1207-1211 | CVCL_M374 | denotes | mast |
| T143 | 1289-1295 | CHEBI:34879 | denotes | NS1619 |
| T144 | 1289-1295 | C086491 | denotes | NS1619 |
| T145 | 1289-1295 | C086491 | denotes | NS1619 |
| T146 | 1379-1383 | CHEBI:23888 | denotes | drug |
| T147 | 1407-1413 | UBERON:0000117 | denotes | airway |
| T148 | 1407-1413 | UBERON:0001005 | denotes | airway |
| T149 | 1425-1437 | GO:0006954 | denotes | inflammation |
| T150 | 1425-1437 | D007249 | denotes | inflammation |
| T151 | 1425-1437 | D007249 | denotes | inflammation |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-43 | Sentence | denotes | Potassium ion channels and allergic asthma. |
| T2 | 44-257 | Sentence | denotes | High-conductive calcium-sensitive potassium channels (BK+Ca) and ATP-sensitive potassium (K+ATP) channels play a significant role in the airway smooth muscle cell and goblet cell function, and cytokine production. |
| T3 | 258-427 | Sentence | denotes | The present study evaluated the therapeutic potential of BK+Ca and K+ATP openers, NS 1619 and pinacidil, respectively, in an experimental model of allergic inflammation. |
| T4 | 428-586 | Sentence | denotes | Airway allergic inflammation was induced with ovalbumine in guinea pigs during 21 days, which was followed by a 14-day treatment with BK+Ca and K+ATP openers. |
| T5 | 587-823 | Sentence | denotes | The outcome measures were airway smooth muscle cells reactivity in vivo and in vitro, cilia beating frequency and the level of exhaled NO (ENO), and the level of pro-inflammatory cytokines in the plasma and bronchoalveolar lavage fluid. |
| T6 | 824-960 | Sentence | denotes | The openers of both channels decreased airway smooth muscle cells reactivity, cilia beating frequency, and cytokine levels in the serum. |
| T7 | 961-1029 | Sentence | denotes | Furthermore, NS1619 reduced ENO and inflammatory cells infiltration. |
| T8 | 1030-1144 | Sentence | denotes | The findings confirmed the presence of beneficial effects of BK+Ca and K+ATP openers on airway defence mechanisms. |
| T9 | 1145-1296 | Sentence | denotes | Although both openers dampened pro-inflammatory cytokines and mast cells infiltration, an evident anti-inflammatory effect was provided only by NS1619. |
| T10 | 1297-1438 | Sentence | denotes | Therefore, we conclude that particularly BK+Ca channels represent a promising new drug target in treatment of airway's allergic inflammation. |
| T1 | 0-43 | Sentence | denotes | Potassium ion channels and allergic asthma. |
| T2 | 44-257 | Sentence | denotes | High-conductive calcium-sensitive potassium channels (BK+Ca) and ATP-sensitive potassium (K+ATP) channels play a significant role in the airway smooth muscle cell and goblet cell function, and cytokine production. |
| T3 | 258-427 | Sentence | denotes | The present study evaluated the therapeutic potential of BK+Ca and K+ATP openers, NS 1619 and pinacidil, respectively, in an experimental model of allergic inflammation. |
| T4 | 428-586 | Sentence | denotes | Airway allergic inflammation was induced with ovalbumine in guinea pigs during 21 days, which was followed by a 14-day treatment with BK+Ca and K+ATP openers. |
| T5 | 587-823 | Sentence | denotes | The outcome measures were airway smooth muscle cells reactivity in vivo and in vitro, cilia beating frequency and the level of exhaled NO (ENO), and the level of pro-inflammatory cytokines in the plasma and bronchoalveolar lavage fluid. |
| T6 | 824-960 | Sentence | denotes | The openers of both channels decreased airway smooth muscle cells reactivity, cilia beating frequency, and cytokine levels in the serum. |
| T7 | 961-1029 | Sentence | denotes | Furthermore, NS1619 reduced ENO and inflammatory cells infiltration. |
| T8 | 1030-1144 | Sentence | denotes | The findings confirmed the presence of beneficial effects of BK+Ca and K+ATP openers on airway defence mechanisms. |
| T9 | 1145-1296 | Sentence | denotes | Although both openers dampened pro-inflammatory cytokines and mast cells infiltration, an evident anti-inflammatory effect was provided only by NS1619. |
| T10 | 1297-1438 | Sentence | denotes | Therefore, we conclude that particularly BK+Ca channels represent a promising new drug target in treatment of airway's allergic inflammation. |